Viewing Study NCT02205333

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:42 AM
Ignite Modification Date: 2026-04-14 @ 10:24 AM
Study NCT ID: NCT02205333
Status: TERMINATED
Last Update Posted: 2017-06-28
First Post: 2014-07-18
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Phase 1b/2 Safety and Tolerability Study of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
Sponsor: MedImmune LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumors View
None Aggressive B-cell Lymphomas View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Advanced Solid tumors View
None Diffuse Large B-cell Lymphoma View
None programmed death 1 View
None programmed dealth ligand 1 View
None cytotoxic T-lymphocyte-associated antigen-4 View
None OX40 ligand View